CervoMed Inc. Common Stock

CRVONASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
2.48 USD
↗ 0.03 (1.22%)AT CLOSE (11:59 AM EDT)
3.37
↗ 0.89 (35.81%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
3.37
↗ 0.89 (35.81%)
🔴Market: CLOSED

CervoMed Inc. Common Stock (CRVO) is currently trading at $2.53. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place CRVO at a fair price relative to peers.

Technical & fundamental data as of Jun 15, 2026.

Open?$2.50
High?$2.66
Low?$2.42
Prev. Close?$2.45
Volume?9.5M
Avg. Volume?104.2K
VWAP?$2.53
Rel. Volume?91.50x
Bid / Ask
Bid?$2.08 × 100
Ask?$2.90 × 100
Spread?$0.82
Midpoint?$2.49
Valuation & Ratios
Market Cap?22.7M
Shares Out?9.3M
Float?5.9M
Float %?63.7%
P/E Ratio?N/A
P/B Ratio?2.14
EPS?-$3.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
15
Market Cap
22.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.cervomed.com
Listed
1996-06-18
Address
20 PARK PLAZA
BOSTON, MA 02116
Phone: (617) 744-4400
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
3
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.57Distress
Confidence?47%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.46%Low
Short Interest?262.8K
Days to Cover?2.9
Free Float5.9M
Avg Daily Volume92.0K
Settlement Date2026-05-29
Financial Health
Current Ratio?3.36Strong
Quick Ratio?3.36Strong
Cash Ratio?1.77Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
71
2.14CHEAP▾
P/S?
Peers
100
S&P
7
10.86HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
20
7.06HIGH▾
Returns & Efficiency
ROE?
S&P
3
-282.9%WEAK▾
ROA?
S&P
3
-198.8%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$14.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist